Clinical Outcomes in Middle Cerebral Artery Trunk Occlusions Versus Secondary Division Occlusions After Mechanical Thrombectomy Pooled Analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials

被引:86
作者
Shi, Zhong-Song [1 ]
Loh, Yince [1 ]
Walker, Gary [2 ]
Duckwiler, Gary R. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Intervent Neuroradiol, Los Angeles, CA 90095 USA
[2] Concentr Med Inc, Mountain View, CA USA
关键词
acute stroke; endovascular treatment; middle cerebral artery; outcome; thrombectomy; TISSUE-PLASMINOGEN ACTIVATOR; RANDOMIZED CONTROLLED-TRIAL; ACUTE CARDIOEMBOLIC STROKE; INTRAARTERIAL THROMBOLYSIS; INTERVENTIONAL MANAGEMENT; INTRAVENOUS THROMBOLYSIS; PROACT II; PART I; RECANALIZATION; SAFETY;
D O I
10.1161/STROKEAHA.109.571943
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The benefit of endovascular revascularization of patients with acute ischemic stroke with middle cerebral artery (MCA) secondary division (M2) occlusions as compared with MCA trunk (M1) occlusions is not known. In this analysis, we compared revascularization status and clinical outcomes in patients with angiographically confirmed MCA M1 versus isolated M2 occlusions treated with mechanical thrombectomy using the Merci Retriever devices. Methods-We retrospectively analyzed the pooled data of patients with MCA strokes from the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials. Patient data were dichotomized into 2 groups: MCA M1 occlusions and isolated M2 occlusions. Baseline characteristics, revascularization rates, hemorrhage rates, complications, outcomes, and mortality were evaluated for both groups. Results-Of 178 patients with MCA occlusion treated in the MERCI and Multi MERCI trials, 84.3% had M1 lesions and 15.7% had isolated M2 lesions. Patients with isolated M2 occlusions were revascularized at a higher rate, required a lower mean number of passes, and were associated with a trend toward shorter mean procedure time than patients with M1 occlusions. No statistically significant differences were found between M2 and M1 groups for symptomatic hemorrhage, clinically significant procedural adverse events, favorable 90-day outcome, or 90-day mortality, although in all instances, the M2 outcomes were numerically better than those in M1 subjects. In multivariate analysis, final revascularization was the strongest independent predictor of good outcome at 90 days. Conclusions-Patients with both MCA M1 occlusions and isolated M2 occlusions can achieve a relatively high rate of revascularization and favorable clinical outcomes after mechanical thrombectomy. In fact, patients with isolated M2 occlusions had a higher rate of revascularization, required fewer passes, and had no increased complications compared with patients with M1 occlusions. (Stroke. 2010;41:953-960.)
引用
收藏
页码:953 / 960
页数:8
相关论文
共 27 条
  • [1] [Anonymous], 1995, N. Engl J Med, V333, P1581, DOI DOI 10.1056/NEJM199512143332401
  • [2] Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion
    Arnold, M
    Schroth, G
    Nedeltchev, K
    Loher, T
    Remonda, L
    Stepper, F
    Sturzenegger, M
    Mattle, HP
    [J]. STROKE, 2002, 33 (07) : 1828 - 1833
  • [3] Recanalization and outcome after intra-arterial thrombolysis in middle cerebral artery and internal carotid artery occlusion - Does sex matter?
    Arnold, Marcel
    Kappeler, Liliane
    Nedeltchev, Krassen
    Brekenfeld, Caspar
    Fischer, Urs
    Keserue, Borbala
    Remonda, Luca
    Schroth, Gerhard
    Mattle, Heinrich P.
    [J]. STROKE, 2007, 38 (04) : 1281 - 1285
  • [4] Stent Placement in Acute Cerebral Artery Occlusion Use of a Self-Expandable Intracranial Stent for Acute Stroke Treatment
    Brekenfeld, Caspar
    Schroth, Gerhard
    Mattle, Heinrich P.
    Do, Do-Dai
    Remonda, Luca
    Mordasini, Pasquale
    Arnold, Marcel
    Nedeltchev, Krassen
    Meier, Niklaus
    Gralla, Jan
    [J]. STROKE, 2009, 40 (03) : 847 - 852
  • [6] The interventional management of stroke (IMS) II study
    Broderick, Joseph P.
    [J]. STROKE, 2007, 38 (07) : 2127 - 2135
  • [7] Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial
    Clark, WM
    Wissman, S
    Albers, GW
    Jhamandas, JH
    Madden, KP
    Hamilton, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2019 - 2026
  • [8] Mechanical thrombectomy of intracranial internal carotid occlusion - Pooled results of the MERCI and multi MERCI part I trials
    Flint, Alexander C.
    Duckwiler, Gary R.
    Budzik, Ronald F.
    Liebeskind, David S.
    Smith, Wade S.
    [J]. STROKE, 2007, 38 (04) : 1274 - 1280
  • [9] Fourie P, 2003, AM J NEURORADIOL, V24, P630
  • [10] Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial
    Furlan, A
    Higashida, R
    Wechsler, L
    Gent, M
    Rowley, H
    Kase, C
    Pessin, M
    Ahuja, A
    Callahan, F
    Clark, WM
    Silver, F
    Rivera, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2003 - 2011